{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "BIVV009",
        "type": {
          "id": "523b625f-b8fe-4909-a41c-c2dba1729cf6",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "fe1af07b-218c-4862-989f-e9a3b91c3122",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Humanized monoclonal antibody (mAb) directed against human complement factor C1s.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Blood transfusion",
        "type": {
          "id": "f1f23655-c221-402b-aeec-be779e76852c",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "8e3b3569-ff26-4cd6-9fc0-9c10cc4bc6ef",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered if Hgb <9 g/dL and symptomatic, or Hgb <7 g/dL and asymptomatic.",
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Iron supplementation",
        "type": {
          "id": "f651e5c9-38c4-441c-9c38-3737329d1084",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "f017f6cd-0e55-4495-8e58-d2578da4a847",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted if patient has been on a stable dose for at least 4 weeks.",
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Erythropoietin",
        "type": {
          "id": "8a479fe0-72a8-4941-ba5f-706eebf05221",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "f5b71c60-3868-48d1-b9ad-7077b4180c3d",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted if patient has been on a stable dose for the previous 3 months."
      },
      {
        "id": "int_5",
        "name": "Corticosteroids",
        "type": {
          "id": "097cc5c1-31d5-4afa-b00b-8b6d07bc840b",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "3dc7828f-44c9-4454-bdb2-cdbb292eebae",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted only as a stable daily dose equivalent to ≤10 mg/day prednisone for previous 3 months."
      },
      {
        "id": "int_6",
        "name": "Vaccinations against encapsulated bacterial pathogens",
        "type": {
          "id": "68d090f2-3905-4d2f-984f-76fc482c2562",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "b0fae83f-b763-41a1-a475-14e5f7c51262",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required vaccinations including Neisseria meningitis, Haemophilus influenzae, and Streptococcus pneumoniae."
      },
      {
        "id": "int_7",
        "name": "Rituximab",
        "type": {
          "id": "f0c87d40-0647-4bbe-9023-85c11222f2b7",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "9a7c7d97-9f0f-4616-b6de-f94e6a4f0fc5",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 3 months (monotherapy) or 6 months (combination therapy) prior to enrollment."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "BIVV009",
        "administrableDoseForm": {
          "id": "25b32097-173c-4555-83f0-4727adcf295d",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "bfe51909-ba09-4638-b80b-3ddc70d5f5e3",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "0ad0c1c2-3586-4bd3-9332-3c6cf3ac4e73",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "6.5 g or 7.5 g",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Bioverativ USA Inc."
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "BIVV009 Part A Regimen",
        "instanceType": "Administration",
        "dose": "6.5 g (if <75 kg) or 7.5 g (if ≥75 kg)",
        "doseFrequency": "Day 0, Day 7, and every 14 days thereafter",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "25 weeks"
      },
      {
        "id": "admin_2",
        "name": "BIVV009 Part B Regimen",
        "instanceType": "Administration",
        "dose": "6.5 g (if <75 kg) or 7.5 g (if ≥75 kg)",
        "doseFrequency": "Every 2 weeks",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "2 to 3 years"
      },
      {
        "id": "admin_3",
        "name": "BIVV009 Loading Dose (Missed Dose)",
        "instanceType": "Administration",
        "dose": "6.5 g or 7.5 g",
        "doseFrequency": "Once (1 week prior to next scheduled dose)",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Single dose"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "BIVV009",
        "instanceType": "Substance",
        "description": "Humanized monoclonal antibody targeting human complement factor C1s"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 7,
      "productCount": 1,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "BIVV009",
        "role": "Investigational Product",
        "description": "Humanized monoclonal antibody (mAb) directed against human complement factor C1s."
      },
      {
        "name": "Blood transfusion",
        "role": "Rescue Medication",
        "description": "Administered if Hgb <9 g/dL and symptomatic, or Hgb <7 g/dL and asymptomatic."
      },
      {
        "name": "Iron supplementation",
        "role": "Concomitant Medication",
        "description": "Permitted if patient has been on a stable dose for at least 4 weeks."
      },
      {
        "name": "Erythropoietin",
        "role": "Concomitant Medication",
        "description": "Permitted if patient has been on a stable dose for the previous 3 months."
      },
      {
        "name": "Corticosteroids",
        "role": "Concomitant Medication",
        "description": "Permitted only as a stable daily dose equivalent to ≤10 mg/day prednisone for previous 3 months."
      },
      {
        "name": "Vaccinations against encapsulated bacterial pathogens",
        "role": "Concomitant Medication",
        "description": "Required vaccinations including Neisseria meningitis, Haemophilus influenzae, and Streptococcus pneumoniae."
      },
      {
        "name": "Rituximab",
        "role": "Concomitant Medication",
        "description": "Prohibited within 3 months (monotherapy) or 6 months (combination therapy) prior to enrollment."
      }
    ],
    "products": [
      {
        "name": "BIVV009",
        "doseForm": "Injection",
        "strength": "6.5 g or 7.5 g",
        "manufacturer": "Bioverativ USA Inc."
      }
    ],
    "substances": [
      {
        "name": "BIVV009",
        "description": "Humanized monoclonal antibody targeting human complement factor C1s"
      }
    ],
    "administrations": [
      {
        "name": "BIVV009 Part A Regimen",
        "dose": "6.5 g (if <75 kg) or 7.5 g (if ≥75 kg)",
        "frequency": "Day 0, Day 7, and every 14 days thereafter",
        "route": "Intravenous",
        "duration": "25 weeks"
      },
      {
        "name": "BIVV009 Part B Regimen",
        "dose": "6.5 g (if <75 kg) or 7.5 g (if ≥75 kg)",
        "frequency": "Every 2 weeks",
        "route": "Intravenous",
        "duration": "2 to 3 years"
      },
      {
        "name": "BIVV009 Loading Dose (Missed Dose)",
        "dose": "6.5 g or 7.5 g",
        "frequency": "Once (1 week prior to next scheduled dose)",
        "route": "Intravenous",
        "duration": "Single dose"
      }
    ],
    "devices": []
  }
}